RECO2: Effects of Six Months of Moderate Resistance- Versus Endurance-Training on Muscle ATP Synthesis in First-Degree Relatives of Patients With Type 2 Diabetes

Sponsor
Landsteiner Institut (Other)
Overall Status
Completed
CT.gov ID
NCT01145092
Collaborator
Mein Hanusch-Krankenhaus (Other), Karl-Landsteiner Institute for Endocrinology and Metabolism (Other), Medical University of Vienna (Other), Lund University (Other), Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy (Other)
16
1
36.9
0.4

Study Details

Study Description

Brief Summary

Life style intervention including diet and exercise is the recommended strategy for prevention of type 2 diabetes mellitus (T2DM). First-degree relatives of patients with type 2 diabetes mellitus have an increased risk of insulin resistance and a lifetime risk of developing type 2 diabetes of 40%- 80%. Poor physical fitness is a strong indicator of an increased risk of developing diabetes.

Long-term endurance exercise training has been shown to increase insulin sensitivity in sedentary young and elderly individuals, first degree relatives of patients with Type 2 diabetes, glucose intolerant obese, or Type 2 diabetic humans. In type 2 diabetic patients, non-diabetic individuals with IGT and sedentary adults after exercise training of different intensity, different duration and different frequency an increase of insulin sensitivity was found.

However, despite the vast knowledge concerning beneficial effects physical activity for the prevention of T2DM (and many other chronic metabolic disorders) to date wide ranging strategies have not been realized satisfactory. Regardless of age, ethnicity, sex or health status the lack of time is the primary reason for the failure to exercise on a regular basis (or is stated as primary reason). Therefore the investigators aimed at investigating whether a controlled endurance/resistance training twice a week over 6 month might be beneficial for healthy, non obese, first degree relatives with T2DM. Therefore the investigators measure parameters associated with the prevention of T2DM like insulin sensitivity, flux through fATPase and fCK, intramyocellular and hepatocellular lipids.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: exercise training, endurance training
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
16 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Effects of Six Months of Moderate Resistance- Versus Endurance-Training on Muscle ATP Synthesis in First-Degree Relatives of Patients With Type 2 Diabetes
Study Start Date :
Feb 1, 2006
Actual Primary Completion Date :
Mar 1, 2009
Actual Study Completion Date :
Mar 1, 2009

Outcome Measures

Primary Outcome Measures

  1. Insulin Sensitivity []

    measured by oral glucose tolerance test

Secondary Outcome Measures

  1. incremental test power, oxygen uptake (VO2 in ml.kg-1.min-1), "aerobic threshold" (RCP= respiratory compensation point) []

    This test was performed on an electronically braked cycle ergometer

  2. ATP-Synthesis []

    measured with 13C NMR

  3. liver lipid content []

    measured with 1H NMR

  4. skeletal muscle lipid content []

    measured by 1H NMR

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • First degree relatives of type 2 diabetic patients

  • Age: 18-50 years

  • BMI <30 kg/m2 (due to limited MR diameter)

  • Normal routine lab tests (blood cell count, kidney, liver, pancreas, thyroid and neuromuscular function)

  • Availability within the local area throughout the study

  • Ability to understand and sign the consent forms

Exclusion Criteria:
  • Current smoking

  • Present drug treatment

  • Regular exercise training

  • Contraindications for MRS studies: claustrophobia and metalliferous implants

  • Pregnancy

  • HIV or Hepatitis

  • Acute disease 2 weeks previous to the examination

  • Heart disease

  • Hypertension (RR>140/95)

  • Liver disease

  • Kidney disease

  • Pulmonary disease

  • Thyroid disease

Contacts and Locations

Locations

Site City State Country Postal Code
1 Landsteiner Institute Vienna Austria 1140

Sponsors and Collaborators

  • Landsteiner Institut
  • Mein Hanusch-Krankenhaus
  • Karl-Landsteiner Institute for Endocrinology and Metabolism
  • Medical University of Vienna
  • Lund University
  • Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy

Investigators

  • Study Director: Michael Roden, Prof., Institute for Clinical Diabetology, German Diabetes Center (Leibniz Center for Diabetes Research), Department of Metabolic Diseases, Heinrich-Heine University and University Clinics Düsseldorf, Germany

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT01145092
Other Study ID Numbers:
  • P15656
First Posted:
Jun 16, 2010
Last Update Posted:
Jun 16, 2010
Last Verified:
Jun 1, 2010

Study Results

No Results Posted as of Jun 16, 2010